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ABSTRACT 
 
Background: Neurocysticercosis is the most common parasitic disease of nervous system in 
humans and the single most common cause of acquired epileptic seizures in the developing 
country. But in Indonesia, it was rarely reported. It has wide variety of clinical manifestation due to 
its pleomorphic nature.  
Subjects and Method: We reported a case of a 12 years old male with seizure and hydrocephalus 
due to intraventricular neurocysticercosis. A ventriculoperitoneal shunt (V-P shunt) performed to 
reduce the intracranial pressure due to hydrocephalus and followed by endoscopic surgery to 
taking sample of the neurocysticercosis and reducing the mass.  
Results: Pathological anatomy examination of excised mass found worm eggs. The patient 
received medications of albendazole and metil prednisolon. 
Conclusion: Intraventricular neurocysticercosis causing hydrocephalus is the commonest 
surgical indication, with V-P shunt placement followed by endoscopic surgery as the procedure of 
choice as it minimally invasive. 
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BACKGROUND 
Cysticercosis is a disease caused by a 
parasitic cyst/larvae infection of the Taenia 
solium tapeworm (T. solium) at the organs 
of the body, such as muscles, eyes, skin, 
brain and other structures. When attacking 
the nervous system, referred to as neuro-
cysticercosis (Gripper and Welburn, 2017). 
Taxonomically, T. solium worms are 
included in Platyhelminthes phylum, 
Cestoda class, cyclophellidea order, Taenii-
dae family, genus taenia. Habitat of this 
worm is on the intestinal wall and its length 
can reach 2-7 meters. The body consists of 
head, neck and strobila consisting of 
proglotid segments. In a mature proglotid 
there are reproductive organs. The terminal 
end of the proglotide will be released from 
the strobila and excreted out with the stool. 
Eggs will be removed at the time before and 
after the proglotid release (Wiria, 2008). 
In the life cycle of T. solium, humans 
are the only definitive host and as the site 
of the growth of adult tapeworm (T. 
solium), while the intermediate host for 
larvae/cysticerci other than humans are 
pigs. Cysticercosis results from swallowing 
eggs from adult tapeworms that being 
excreted along with infected human feces. 
When the egg is exposed to stomach acid 
and intestinal fluid, its capsule will be 
damaged and the embryo will be released 
and then turned into a larva cyst called 
oncosphere. This oncosphere will stick and 
penetrate the small intestine into the blood 
vessel system and spread throughout the 
body, including to the brain, muscles, eyes, 
and other organ structures. By the time the 
oncosphere reach the brain, it causes very 
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little immune response, so it can survive for 
several years.  
T. solium could extend to 1 cm in 2-3 
months. Adult tapeworms could reach a 
length of 2-7 meters and produce more 
than 1000 proglottids and each proglottids 
contains about 50,000 eggs and lived in the 
small intestine for years (Wiria, 2008). 
Outside the nervous system, cysticer-
cosis does not cause significant symptoms, 
whereas in the nervous system it will cause 
various clinical manifestations due to its 
pleomorphic origin, from asymptomatic to 
endanger patient’s live, such as headache, 
dizziness, seizures, stroke, dementia/ 
neurobehavioral disorder, diplopia, hydro-
cephalus, epilepsy, migraine, arachnoiditis, 
and increased intracranial pressure. The 
symptoms could be subacute or chronic and 
depend on location, number of parasites, 
stage of cyst at site, and patient’s immune 
response. Manifestations of seizures that 
may arise can be general tonic clonic seizu-
res or simple or complex partial seizures 
(Gripper and Welburn, 2017). 
Neurocysticercosis is the leading 
cause of acquired seizures and epilepsy in 
developing countries, especially in Latin 
America, India, Africa, and China. In Indo-
nesia this disease is endemic especially in 
North Sumatra, Bali, Papua, Timor, Flores, 
North Sulawesi and West Kalimantan. Raka 
(1998) reported that 68% of patients with 
neurocysticercosis are having epilepsy 
attack. In the United States there is an 
increase of the neurocysticercosis incidence 
since the 1980s due to immigration from 
Latin America to the US. The spreading in 
non-endemic areas associated with immi-
grants, as neurocysticercosis is a disease 
that transmission can occur between 
humans (Wandra et al., 2007). 
Case Report 
A 12 years old boy with complaint of 
headache that being felt since 6 months ago 
and become worsening, unconscious (-), 
vomiting (-), seizures (-), history of trauma 
(-). The patient lives in a poor sanitation 
environment (neighboring chicken and pig 
breeders). Two months ago, he was brought 
by his family to RS PKU Muhammadiyah 
Solo, handled by Neurologist, head CT-scan 
performed, hydrocephalus non comunicans 
and intraventricular mass have been found. 
The patient was then consulted to a 
neurosurgeon and V-P shunt surgery was 
being performed. Afterwards head MRI was 
being performed, multiple solid dominant 
masses at the right and left lateral 
intraventricles have been found, especially 
at the anterior cornu, ventricle III, accom-
panied by left lateral ventricular dilatation 
(hydrocephalus non comunicans), resulting 
slight midline shifting, concluded as 
choroid tumor plexus. 
 
 
 
Figure 1. Head CT-scan ahead 
of V-P Shunt 
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Figure 2. Head MRI and MRA ahead 
of neuroendoscopic tumor excision 
 
A month ago, a neuroendoscopic 
surgery was performed with partial excision 
of tumor mass. From the results of the PA, 
worm eggs have being found and suspected 
as an intraventricular parasitic worm 
infection. Patient treated with medications 
of Albendazole and Metil Prednisolone for 1 
month. 
 
 
Figure 3. Pathological anatomy 
results post neuroendoscopic 
excision of tumor 
DISCUSSION 
Neurocysticercosis has no prevalence of age 
or gender. Children patients are usually 
asymptomatic, and there are some 
differences in child and adult cases: 
(Zammarchi et al., 2016). 
• Children are rarely affected by neuro-
cysticercosis due to the difference of 
transmission mechanism and immune 
system response to the parasite. 
• Asymptomatic neurocysticcosis is more 
commonly detected by MRI in patients 
aged > 15 years than < 15 years. 
• Adults have higher incidence of 
headache, extra parenchymal neuro-
cysticercosis, increased intra cranial 
pressure, changes in cerebrospinal fluid 
examination results, focal neurodeficitis, 
depression syndrome, and seizure 
recurrence after discontinuation of anti 
convulsant administration. 
• Children are more likely to experience 
convulsions and single colloidal 
parenchymal cysts 
When cysticercosis reaches the brain, 
there are 6 clinical syndromes that could 
manifestate based on the location of the 
cyst, namely:  
1. Asymptomatic neurocysticercosis 
Some patients do not show significant 
symptoms and the finding of neuro-
cysticercosis is usually incidental. 
2. Parenchymal neurocysticercosis 
The cysticercosis that develops in the 
brain's parenchymal tissue generally 
located on the border between substansia 
alba and substansia gricea and could be 
asymptomatic. Symptoms arise due to mass 
effect. The cysts may live in active form, 
degenerate or dead and calcified. The 
presence of live and degenerated cysts leads 
to an inflammatory response, headache and 
in some cases could lead to death. 
Anthelminthic treatment should be given as 
soon as possible, as it will decrease the 
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number of cysts present in the brain 
(Rajshekhar, 2016; Zafar, 2016; Gripper 
and Welburn, 2017). 
3. Subarachnoid neurocysticsercosis 
(racemose) 
This form occurs because the cyst located in 
the subarachnoid space and grows abnor-
mally into a large mass and/or racemose 
cyst and supressing surrounding structures 
and endanger the patient due to mass 
effect. Clinical symptoms, approaches and 
treatments are different from those in 
parenchyma. Clinical symptoms are often 
found to be a sign of meningeal excitability, 
due to the inflammatory process of the 
meninges and, if continued, may lead to 
lacunar and hydrocephalus infarction. In 
general, prognosis is worse than parenchy-
mal neurocysticercosis (Zafar, 2016). 
The inflammation process because of 
this cyst could be located in suprasella, 
quadrigeminal sisterna and aquaductus 
Sylvii and usually accompanied by signs of 
meningitis and increased intracranial 
pressure. The inflammation could lead to 
lacunar infarction and suppression of the 
cranial nerves located adjacent to this 
inflammatory process. If the nerve of the 
eyeball is pressed, the muscles of the eye-
ball become paralyzed, resulting in diplo-
pia. If optic nerve and optic chiasma affect-
ed, visual field disruption and eyesight 
decreased may occur. 
Neurocysticercosis in the bacillary 
system is often fatal, especially if the lesions 
are extensive and located in the serebro-
pontine angle and in the fissurea Silvii. If 
the ongoing inflammatory process conti-
nues, it is necessary to provide adequate 
anti-inflammatory medications (Rajshe-
khar, 2016; Gripper and Welburn, 2017). 
4. Intraventricular neurosistisercosis 
The cyst located in the ventricle and 
interference the CSF flow resulting to 
hydrocephalus and increased intracranial 
pressure (Jensen and Post, 2016). 
5. Spinal neurocysticercosis 
This is a rare form, only 1-5% of all cases. 
However, it could leads to severe neuro-
cysticercosis when it occurs. It could be 
located intramedullary or extramedullary. 
The most common symptoms are back pain 
and radiculopathy. Extramedullary is more 
frequent with symptoms of radicular pain, 
limb weakness and paresthesia, whereas 
intramedullary will cause paraparese, sen-
sory and sphincter disorders (Rajshekhar, 
2016; Gripper and Welburn, 2017). 
6. Ocular neurocysticercosis 
It occurs when cysticercosis reaches the 
eyeball, subconjunctiva, extraocular muscle 
and subretinal space with different symp-
toms on each location. Subretinal space is 
the most common place. The symptoms 
could be visual impairment, visual field dis-
ruption, retinal edema, hemorrhage, even 
severe blindness. Cysts located in the vitre-
ous could causing eyesight decreased and 
often the patient feels there is something 
moving in the eye. Cysts in the front 
chamber may induce severe iridocyclitis, 
while intraorbital retro-ocular cysticercosis 
may lead to eyesight decreased due to 
supression of the optic nerve (Rajshekhar, 
2016; Gripper and Welburn, 2017). 
Neurocysticercosis is the leading 
cause of acquaired epileptic seizures (70-
90%) in adulthood, especially in endemic 
areas such as in Latin America, Africa and 
Asia (Zammarchi et al. 2016). Seizures may 
manifestate as generalized clonic tonic 
seizures or simple or complex partial 
seizures, although generally the simple 
partial seizure is the most common. The 
seizures occured due to:  
• Inflammatory process due to the 
presence of live (active) cysts or cysts 
that are damaged (degeneration) 
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• Secondary to vasculitis and infarction 
due to subarachnoid disturbance 
• Calcification due to the presence of dead 
cysts (Gripper and Welburn, 2017). 
Epileptogenesis in patients with neuro-
cysticercosis may caused by various factors, 
such as: inflammation, gliosis, genetic, and 
predilection of cyst in the frontal lobe and 
temporal lobes. Patient’s immune response 
to degeneration cysts is an important factor 
in epileptogenesis. In women and children, 
there is a clear response to parasitic 
infection in the brain, whereas in adults the 
response varies. Response in a patient's 
body also varies, i.e. excessive inflamma-
tory responses can occur at one cyst, while 
at other cysts around it there are no signs of 
inflammation, so the focus of the seizure 
usually lies in cysts that degenerate or 
experience inflammation. There are reports 
showing the damage to the blood-brain 
barrier from the release of the serum 
cysticercosis component to the brain that 
inducing seizures. 
Administration of antihelmintic also 
causing initiation of inflammatory response 
from the host to cysts that resemble 
radiological and histologic features such as 
degenerated cysts, increasing the risk of 
seizures. Chronic seizures are often asso-
ciated with calcified granulomas, where 
patients have a high risk of recurrent 
seizures. The most epileptogenic cysts are 
those that are active and in the 
degeneration process. The cyst degenerate 
about 6 to 12 months after the start of 
treatment (Rajshekhar, 2016). 
Headache could occur as a chronic 
headache accompanied by nausea and 
vomiting, and if symptoms of increasing 
intracranial pressure occured, hydrocepha-
lus could be developing, due to cysticercosis 
located in the ventricular system blocking 
the CSF flow. Hydrocephalus could be 
either comunicating hydrocephalus or non 
communicating hydrocephalus. The comu-
nicating hydrocephalus occured due to 
inflammatory process, fibrosis of the 
arachnoid villi or inflammatory reaction in 
the menigen and blockage in the Luschka 
and Magendie foramen. Non comunicating 
hydrocephalus occured due to the presence 
of cysts in the intraventricles (Zafar, 2016). 
Stroke that occurs in patients with 
neurocysticercosis could be infarction or 
bleeding. Infarction stroke occured due to 
blockage or blood vessels damage, while 
bleeding occured due to rupture of the 
aneurysm, both as a result of further cyst 
suppression (Zafar, 2016). 
Neurobehavior disorders including 
depression and psychosis occured due to an 
increase in intracranial pressure. Diplopia 
occured due to increased intracranial 
pressure, arachnoiditis, or suppression of 
the III, IV, and VI cranial nerves.  
Radiological examinations including 
X-ray examination, CT-Scan and MRI will 
resulting various image depending on the 
location and stage of the cyst, namely: 
(Zafar 2016; Gasparetto et al., 2016; 
Gripper and Welburn 2017). 
• In the brain parenchyme : 
CT-Scan will show a skolex inside nodule as 
a hole with dot as a pathognomonis sign of 
neurosistcercosis. In subsequent stages, 
perilesional edema and contrast absorption 
in degenerated cysts will occured. This 
stage is called colloidal stage and is often 
referred to as the "acute phase of ence-
phalitis" of neurocysticercosis caused by an 
immune reaction of the patient. 
MRI examination will obtained an 
image of lesions with surrounding edema 
with a thick wall, best seen in MRI with 
fluid-attenuated inversion recovery 
(FLAIR). Granular cysticercosis appears as 
a hyperintense nodular lesion surrounded 
by edema or gliosis in MRI with contrast. In 
Indonesian Journal of Medicine (2018), 3(1): 56-64 
https://doi.org/10.26911/theijmed.2018.03.01.08 
62   e-ISSN: 2549-0265 
a dead cysticercosis, CT-Scan and MRI will 
show calcification. 
• On basillary system: 
Head CT-Scan will not show any results, 
while in MRI a Leptomeningeal enhance-
ment at the cranial base will be seen clearly. 
• In the ventricle: 
Initial CT-Scan will show isodense lesion 
with CSF, making it difficult to see, but in 
the later phase it will appear as a cystic 
lesion. 
On MRI examination, ventricular cyst 
will be seen clearly, especially when using 
FLAIR technique. The ventricular cysts may 
migrate locally if the patient's head is 
moved (ventricular migration sign). 
• In the spinal: 
CT-Scan will show symmetrical enlarge-
ment of the spinal cord (intramedullary 
cyst) or pseudoreticular spinal canal forma-
tion (leptomeningeal cyst). 
MRI of intramedullary cysticercosis 
will show a ring-enchancing lesion, whereas 
skolex will give a thick, oval nodule. 
Laboratory tests are not always 
supporting the diagnosis. Eosinophilia in 
peripheral blood examination is only 
positive in 0-37% of cases. Serological tests 
that aim to detect antibodies, antigens and 
measurements of oligoclonal immunoglo-
bulins or IgE, the sensitivity and specificity 
of antibody and cysticercosis antigens 
highly dependent on the examination 
sample (cerebrospinal or serum fluid), cyst 
activity (active or inactive) and examination 
methods. However, most of the tests that 
use the unfractionated antigen give rise to 
false-positive due to the ability of the cyst to 
interact with the immunoglobulin and 
false-negative due to the high threshold 
values set by the laboratory to avoid false-
positive results (Rajshekhar, 2016; Gripper 
and Welburn, 2017) 
An enzyme-linked immune-transfer 
blot (EITB) has a high specificity for T. 
solium infection and no false positive result 
found, with a virtually 100% sensitivity in 
patients with active multiple parenchymal 
cysts or extraparenchymal neurocystcerco-
sis. In patients with single parenchymal 
lesion, negative result will occur in more 
than 30% of patients and only positive in 
calcified cysticercosis. However, in patients 
with two or more cystic or contrast-
absorbing lesions, the specificity is nearly 
100% and the sensitivity is 94-98%. The 
serum gives a more sensitive result than 
CSF. Levels of parasitic antigen decreased 
after 3 months of albendazole adminis-
tration. DNA testing is another diagnostic 
technique for ensuring T. solium (Rajshe-
khar, 2016; Gripper and Welburn 2017). 
Del Brutto et al. (2001) provided the 
diagnostic criteria for neurocysticercosis to 
facilitate diagnosis (See Table 1) (Gripper 
and Welburn, 2017). 
Treatment of neurocysticercosis 
patients influenced by various factors, such 
as cyst location, cyst stage, cyst number, 
inflammation process, cyst size and severity 
of symptoms. Treatments include: (Zafar, 
2016; Rajshekhar, 2016; Gripper and 
Welburn, 2017). 
a. Symptomatic treatment 
Symptomatic treatment is given to over-
come the symptoms caused by the parasite 
as well as the result of anti-parasitic 
treatment. Preparations tahat being used 
include: 
• Anti-convulsant such as phenytoin or 
carbamazepine generally could control 
the occuring seizures. 
• Corticosteroids administered as anti-
inflammatory to control the inflamma-
tory response signs and symptoms that 
occur, and should be administered in the 
short term. Long-term administration 
required in severe neurocystisercosis, 
although it may causing severe and life-
threatening side-effects. 
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• Manitol may be administered to reduce 
occuring edema. 
Methotrexate may be administered to 
control the prolonged inflammatory 
process in meninges. 
Table 1. The “Del Brutto Criteria” for diagnosis of NCC 
Absolute 
criteria 
Major criteria Minor criteria Epidemiological 
criteria 
Diagnosis 
Histology: 
Visualization of 
parasite from 
biopsy at brain 
or spinal cord 
lesion. 
Neuro-
imaging: 
Scolex visible 
within cystic 
lesion. 
Fundoscopy: 
Evidence of sub-
retinal parasites 
Neuro-
imaging: 
Lesion highly 
suggestive of 
NCC 
EITB assay: 
Positive results 
for detection of 
T. solium 
antibodies. 
Cysticidal 
drug therapy: 
Lesion 
resolution 
following 
treatment with 
albendizole or 
praziquantel 
Neuroimaging: 
Lesion suggestive 
of NCC 
Clinical 
manifestation: 
Symptoms 
suggestive of NCC 
CSF ELISA: 
Positive detection 
for detection of T. 
solium  
antibodies or 
antigens 
Evidence of 
cysticercosis 
outside the CNS. 
Patient country of 
origin endemic for 
NCC. 
Patient currently 
resides in NCC 
endemic area. 
Patient frequently 
travels to areas 
where NCC is 
endemic. 
There is evidence 
that patient 
household has had 
contact with T. 
solium infection 
Definitive: 
1 absolute 
OR 
2 major plus 1 
minor/1 
epidemiological. 
Probable: 
1 major plus 2 
minor 
OR 
1 major plus 1 
minor plus 1 
epidemiological 
OR 
3 minor plus 1 
epidemiological 
Source: Del Brutto et al. (2001). 
 
b. Anti parasitic treatment 
The choice for neurocysticerckosis medi-
cations are albendazole 15 mg/kg/day for 
one month and praziquantel 50 mg/kg/ day 
for two weeks, which has 60-85% range of 
eradicating parasites at the brain paren-
chym. Vasques and Sotelo in their study 
stated that administration of albendazole 
can decrease the occurrence of seizures in 
patients with cysts less than or equal to 20, 
and patients will experience seizure free 
after 3 years. Albendazole has better pene-
tration into the CSF and its concentration is 
not affected by corticosteroids, while prazi-
quantel interacts with corticosteroids and 
also lowering the serum levels of phenytoin 
and carbamazepine. 
Some authors suggest that adminis-
tration of antiparasitic drugs may be 
unfavorable, as they may worsen the pati-
ent condition, such as the gastrointestinal 
effects, seizures, increased intracranial 
pressure, and sometimes death. Neurologic 
symptoms usually occur on the second day 
until the fifth day of antiparasit treatment, 
allegedly caused by the inflammatory 
response due to cysticercosis death, so 
corticosteroids should be given. 
c. Surgery 
Indications for surgical intervention and 
recommended procedures are as follows:  
• Hydrocephalus due to an intraventri-
cular cyst: placement of a V-P shunt, 
followed by surgical extirpation of the 
cysts and subsequent medical treatment. 
• Multiple cysts in subarachnoid space 
(i.e. the racemose form): urgent surgical 
extirpation 
• Obstruction due to arachnoiditis: place-
ment of V-P shunt, followed by cortico-
steroid administration and subsequent 
medical treatment (Zafar 2016). 
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Other several specific indications for 
surgery:  
• Large parenchymal colloid cysts or 
racemose cysts that causing mass effects. 
• Atypical neurocysticercosis which requi-
res a definite diagnosis. 
• Epilepsy that does not improve with 
administration of anti-convulsant drugs. 
• Ocular or spinal lesions (either intrame-
dullary/ extramedullary) (Rajshekhar 
2016). 
Intraventricular cysts are best treated 
with endoscopic excision as procedure of 
choice compared to open craniotomy and 
microsurgery excision since the last 2 
decades. Neuroendoscopic surgery is a 
minimally invasive surgery performed 
through a single burr hole, and often act as 
a curative therapy in a single intra-
ventricular cyst and has minimal surgical 
side effects when performed by experienced 
surgeons. Although there are concerns 
about the possibility of anaphylactic 
reactions due to rupture of the cyst during 
surgery, there are no reports about it 
(Rajshekhar 2016). 
Avoid consuming foods contaminated 
by tapeworm eggs brought by taeniasis 
carriers and prevent autoinfection is the 
main effort to prevent cysticercosis. 
Furthermore, eradicating source of infect-
ion transmission in patients with taeniasis 
by removing the worms and skolex is also 
important. Other means to prevent tape-
worms infection are by sanitation improve-
ment, meat health inspection, as well as 
meat cooking and processing (Zafar, 2016; 
Rajshekhar, 2016; Gripper and Welburn, 
2017). 
Based on the results, it can conclude 
that intraventricular neurocysticercosis 
causing hydrocephalus is the commonest 
surgical indication, with V-P shunt place-
ment followed by endoscopic surgery as the 
procedure of choice as it minimally 
invasive. 
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